Aberrant E-cadherin expression associated with loss of differentiation and advanced stage in human pancreatic cancer

Anticancer Research

Volumn 18, Issue 6 A, 1998, Pages 4177-4180

  Karayiannakis, Anastasios J ^a,e   Syrigos, Konstantinos N ^b   Chatzigianni, Emmy ^c   Papanikolaou, Spilios ^a   Alexiou, Dimitrios ^d   Kalahanis, Nicolaos ^d   Rosenberg, Theophilos ^d   Bastounis, Elias ^d  

^a Department of Rheumatology   (Greece)

^b ST BARTHOLOMEW S HOSPITAL   (United Kingdom)

^c IKA   (Greece)

^d UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^e NONE   (Greece)

Author keywords

Cell adhesion; E cadherin; Pancreatic cancer

Indexed keywords

UVOMORULIN;

ADVANCED CANCER; ARTICLE; CELL JUNCTION; CLINICAL ARTICLE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; PANCREAS CANCER; PRIORITY JOURNAL;

CADHERINS; CELL MEMBRANE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; INTERCELLULAR JUNCTIONS; LYMPHATIC METASTASIS; NEOPLASM METASTASIS; NEOPLASM STAGING; PANCREAS; PANCREATIC NEOPLASMS; RETROSPECTIVE STUDIES;

EID: 0032410023     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Liotta LA and Stracke ML: Tumor invasion and metastases: biochemical mechanisms. Cancer Treat Res 40: 223-238, 1988.
2. Hart IR and Saint A: Biology of tumour metastasis. Lancet 339: 1453-1457, 1992.
3. Schiffmann E: Motility as a principal requirement for metastasis. Cancer Invest 8: 673-674, 1990.
4. Gumbiner BM: Cell adhesion: the molecular basis of tissue architecture and morphogenesis. Cell 84: 345-357, 1996.
5. Vleminckx K, Vakaet LJr, Mareel M, Fiers W and Van Roy F: Genetic manipulation of E-cadherin expression by epithelial tumor cells reveals an invasion suppressor role. Cell 66: 107-119, 1991.
6. Frixen UH, Behrens J, Sachs M, Eberle G, Voss B, Warda A, Lochner D and Birchmeier W: E-cadherin-mediated cell-cell adhesion prevents invasiveness of human carcinoma cells. J Cell Biol 113: 173-185, 1991.
7. Weinel RJ, Neumann K, Kisker O and Rosendahl A: Expression and potential role of E-cadherin in pancreatic carcinoma. Int J Pancreatol 19: 25-30, 1996.
8. Klöppel G and Maillet B: Histological typing of pancreatic and periampullary carcinoma. Eur J Surg Oncol 17: 139-152, 1991.
9. Hermanek P: Staging of exocrine pancreatic carcinoma. Eur J Surg Oncol 17: 167-172, 1991.
10. Pignatelli M, Ansari TW, Gunter P, Liu D, Hirano S, Takeichi M, Klöppel G and Lemoine NR: Loss of membranous E-cadherin expression in pancreatic cancer: correlation with lymph node metastasis, high grade, and advanced stage. J Pathol 174: 243-248, 1994.
11. Jankowski JA, Newham PM, Kandemir O, Hirano S, Takeichi M and Pignatelli M: Differential expression of E-cadherin in normal, metaplastic and dysplastic oesophageal mucosa: a putative biomarker. Int J Oncol 4: 441-448, 1994.
12. Oka H, Shiozaki H, Kobayashi K, Tahara H, Tamura S, Miyata M, Doki Y, Iihara K, Matsuyoshi N, Hirano S, Takeichi M and Mori T: Immunohistochemical evaluation of E-cadherin adhesion molecule expression in human gastric cancer. Virchows Arch [A] Pathol Anat Histopathol 421: 149-156, 1992.
13. Gagliardi G, Kandemir O, Liu D, Guida M, Benvestito S, Ruers TGM, Benjamin IS, Northover JMA, Stamp GWH, Talbot IC and Pignatelli M: Changes in E-cadherin immunoreactivity in the adenoma-carcinoma sequence of the large bowel. Virchows Arch 426: 149-154, 1995.
14. Siitonen SM, Kononen JT, Helin HJ, Rantala IS, Holli KA and Isola JJ: Reduced E-cadherin expression is associated with invasiveness and unfavorable prognosis in breast cancer. Am J Clin Pathol 105: 394-402, 1996.
15. Syrigos KN, Krausz T, Waxman J, Pandha H, Rowlinson-Busza G, Verne J, Epenetos AA and Pignatelli M: E-cadherin expression in bladder cancer using formalin-fixed, paraffin-embedded tissues: correlation with histopathological grade, tumour stage and survival. Int J Cancer 64: 367-370, 1995.
16. Richmond PJM, Karayiannakis AJ, Nagafuchi A, Kaisary AV and Pignatelli M: Aberrant E-cadherin and α-catenin expression in prostate cancer correlation with patient survival. Cancer Res 57: 3189-3193, 1997.